NASDAQ
ANI Pharmaceuticals, Inc. (ANIP) has a price/fcf ratio of 9.24x as of Monday, May 25, 2026. This represents a 479.95% increase compared to its 12-month average of -2.43x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.